All Access Articles |
- Verastem Discontinues KRAS G12C Trial | 2025-12-31 | PHARMACEUTICAL
- Verastem Oncology Announces Leadership Changes | 2025-12-22 | PHARMACEUTICAL
- Verastem Announces Strong Response Rate in Pancreatic Cancer Trial | 2025-05-23 | PHARMACEUTICAL